IP Library › Granted Patent US 9,938,367
Granted Patent B2
US 9,938,367 · App. 15/630,048 · Granted Apr 10, 2018

Polymer particles

Inventors: Gregory M. Cruise (Rancho Santa Margarita, CA); Gloria Hincapie (Tustin, CA); Clayton Harris (Tustin, CA)
Assignee: Terumo Corporation
C08F220/38A61K9/0029A61K9/1635A61L24/001A61L24/06A61L31/048C08F220/56A61L2430/36C08F222/1006C08F222/385C08F2220/382C08F2222/408Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,938,367
App. No.
15/630,048
Granted
Apr 10, 2018
Kind
B2
Abstract

Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.

Claims (26)

1. An embolic system including:

a delivery device; and

an embolic solution including polymer particles, wherein the polymer particles include:

an acrylate, acrylamide, methacrylamide, methyl methacrylate, or a combination thereof, and

a crosslinker,

wherein the polymer particles have a spherical diameter between about 40 μm and about 1,200 μm.

2. The embolic system of claim 1 , wherein the polymer particles are susceptible to degradation through hydrolysis or enzymatic action, and wherein the degradation provides less than about 10% of the polymer particles intact after about 5 days.

3. The embolic system of claim 1 , wherein the spherical diameter is between about 75 μm and about 1,200 μm.

4. The embolic system of claim 1 , wherein the crosslinker includes at least two functional groups.

5. The embolic system of claim 1 , wherein the crosslinker includes at least one linkage susceptible to degradation through hydrolysis or enzymatic action.

6. The embolic system of claim 1 , wherein the crosslinker is bis-glycidyl amino alcohol,

wherein a, b, c, d, e, and f are each independently 1-20.

7. The embolic system of claim 5 , wherein the at least one linkage is an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, a peptide cleavable by matrix cathepsins, or a combination thereof.

8. The embolic system of claim 1 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins.

9. The embolic system of claim 1 , wherein the crosslinker is bis-glycidyl amino alcohol or bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

10. The embolic system of claim 1 , wherein the delivery device is a catheter.

11. The embolic system of claim 1 , wherein the delivery device is a microcatheter.

12. The embolic system of claim 1 , wherein the delivery device is a needle.

13. The embolic system of claim 1 , wherein the delivery device and the embolic solution are sterilized.

14. The embolic system of claim 1 , wherein the embolic solution includes a monomer including an ionizable functional group.

15. The embolic system of claim 14 , wherein the ionizable functional group is basic or acidic.

16. The embolic system of claim 1 , wherein the embolic solution includes a radiopaque contrast agent.

17. The embolic system of claim 1 , wherein the embolic solution includes a dye.

18. The embolic system of claim 1 , wherein the embolic solution is provided in a vial.

19. The embolic system of claim 1 , wherein the embolic solution is provided in a syringe.

20. The embolic system of claim 1 , wherein the polymer particles have a circularity greater than about 0.9.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2017
From: CRUISE, GREGORY M.; HINCAPIE, GLORIA; HARRIS, CLAYTON
To: MICROVENTION, INC.
Reel/Frame 042787/0314 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2017
From: MICROVENTION, INC.
To: TERUMO CORPORATION
Reel/Frame 042787/0462 →
Continuity (4)
Continuation 15639213 · Dec 5, 2016
Continuation 14491776 · Sep 19, 2014
Provisional Application 61880036 · Sep 19, 2013
Related Publication 20170283536A1 · Oct 5, 2017